BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23832257)

  • 1. Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.
    Slattery ML; John EM; Torres-Mejia G; Lundgreen A; Lewinger JP; Stern MC; Hines L; Baumgartner KB; Giuliano AR; Wolff RK
    Int J Cancer; 2014 Feb; 134(3):629-44. PubMed ID: 23832257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
    Slattery ML; Lundgreen A; Wolff RK
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E140-50. PubMed ID: 23794399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.
    Pellatt AJ; Wolff RK; John EM; Torres-Mejia G; Hines LM; Baumgartner KB; Giuliano AR; Lundgreen A; Slattery ML
    PLoS One; 2013; 8(11):e80554. PubMed ID: 24278290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.
    Roberts MR; Sucheston-Campbell LE; Zirpoli GR; Higgins M; Freudenheim JL; Bandera EV; Ambrosone CB; Yao S
    Mol Carcinog; 2017 Mar; 56(3):1000-1009. PubMed ID: 27597141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women.
    Dorjgochoo T; Zheng Y; Gao YT; Ma X; Long J; Bao P; Zhang B; Wen W; Lu W; Zheng W; Shu XO; Beeghly-Fadiel A
    Cancer Epidemiol; 2013 Oct; 37(5):619-24. PubMed ID: 23850146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of polymorphisms of angiogenesis genes with breast cancer.
    Schneider BP; Radovich M; Sledge GW; Robarge JD; Li L; Storniolo AM; Lemler S; Nguyen AT; Hancock BA; Stout M; Skaar T; Flockhart DA
    Breast Cancer Res Treat; 2008 Sep; 111(1):157-63. PubMed ID: 17891484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study.
    Slattery ML; Lundgreen A; John EM; Torres-Mejia G; Hines L; Giuliano AR; Baumgartner KB; Stern MC; Wolff RK
    Nutr Cancer; 2015; 67(2):292-304. PubMed ID: 25629224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy homeostasis genes and breast cancer risk: The influence of ancestry, body size, and menopausal status, the breast cancer health disparities study.
    Slattery ML; Lundgreen A; Hines L; Wolff RK; Torres-Mejia G; Baumgartner KN; John EM
    Cancer Epidemiol; 2015 Dec; 39(6):1113-22. PubMed ID: 26395295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
    Slattery ML; John E; Torres-Mejia G; Stern M; Lundgreen A; Hines L; Giuliano A; Baumgartner K; Herrick J; Wolff RK
    PLoS One; 2013; 8(5):e63165. PubMed ID: 23696797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.
    Slattery ML; Herrick JS; Torres-Mejia G; John EM; Giuliano AR; Hines LM; Stern MC; Baumgartner KB; Presson AP; Wolff RK
    Carcinogenesis; 2014 Aug; 35(8):1750-9. PubMed ID: 24670917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
    Beeghly-Fadiel A; Shu XO; Lu W; Long J; Cai Q; Xiang YB; Zheng Y; Zhao Z; Gu K; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):33-41. PubMed ID: 21119072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.
    Slattery ML; Lundgreen A; Welbourn B; Wolff RK; Corcoran C
    Mutat Res; 2012 Jun; 734(1-2):30-40. PubMed ID: 22531693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
    Slattery ML; John EM; Stern MC; Herrick J; Lundgreen A; Giuliano AR; Hines L; Baumgartner KB; Torres-Mejia G; Wolff RK
    Breast Cancer Res Treat; 2013 Aug; 140(3):587-601. PubMed ID: 23912956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the CHIEF pathway on colorectal cancer-specific mortality.
    Slattery ML; Lundgreen A
    PLoS One; 2014; 9(12):e116169. PubMed ID: 25541970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients.
    Abdelgalil AA; Monir R; Elmetwally M; Ghattas MH; Bazeed FB; Mesbah NM; Abo-Elmatty DM; Mehanna ET
    Biochem Genet; 2024 Feb; 62(1):547-573. PubMed ID: 37392242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study.
    Slattery ML; Hines LH; Lundgreen A; Baumgartner KB; Wolff RK; Stern MC; John EM
    Cancer Causes Control; 2014 Sep; 25(9):1211-25. PubMed ID: 24993294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
    Eng L; Azad AK; Qiu X; Kong QQ; Cheng D; Ying N; Tse A; Kuang Q; Dodbiba L; Renouf DJ; Marsh S; Savas S; Mackay HJ; Knox JJ; Darling GE; Wong RK; Xu W; Liu G; Faluyi OO
    Carcinogenesis; 2015 Sep; 36(9):956-62. PubMed ID: 26014353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.
    Makhoul I; Todorova VK; Siegel ER; Erickson SW; Dhakal I; Raj VR; Lee JY; Orloff MS; Griffin RJ; Henry-Tillman RS; Klimberg S; Hutchins LF; Kadlubar SA
    PLoS One; 2017; 12(1):e0168550. PubMed ID: 28045923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.
    Slattery ML; Lundgreen A; Stern MC; Hines L; Wolff RK; Giuliano AR; Baumgartner KB; John EM
    Cancer Causes Control; 2014 Mar; 25(3):293-307. PubMed ID: 24337772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.
    Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; John EM; Hines LM; Stern MC; Giuliano AR; Torres-Mejia G; Brock GN; Groves FD; Kerber RA; Wolff RK; Slattery ML
    Breast Cancer Res Treat; 2013 Sep; 141(2):287-97. PubMed ID: 24036662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.